Jump to content



Recommended Posts

I checked with some of my colleagues. In my area a 30-day supply of Tarceva 150mg. has increased by ~ $350 over the last 3 months. If the price keeps climbing like this I expect closer prior authorization scrutiny by MRC's. I still think that Iressa got a bum rap. I hope that AZN can turn the drug's image around. It would provide some competition and help price stability. There could be a formulation issue involved with Iressa by my gut tells me that the drug just fell victim to some of the pitfalls of being the first one out of the gate and maybe some poorly designed clinical trials. JMO


Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...

Important Information

By using this site, you agree to our Terms of Use. We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.